Today I got an email from Pharmac, in response to a submission I sent, the day before I heard the momentous news about generics, last September. I'm G3 and was contemplating how to raise the money for the harvoni I was told I should take. 5 minutes on the internet showed me it should be sof /dac not sof/ led for me, particularly if it meant selling everything we have to get it.
As a result of the Government’s budget announcement today, we have opened consultations on funding proposals for seven medicines, including the hepatitis C treatments ledipasvir with sofosbuvir (Harvoni), paritaprevir with ritonavir and ombitasvir copackaged with dasabuvir (Viekira Pak) and paritaprevir with ritonavir and ombitasvir copackaged with dasabuvir and ribavirin (Viekira Pak-RBV). Noting your previous response to PHARMACs request for information on hepatitis C treatments, we thought this may be of interest to you.
You can read about these proposals on our website. I have attached a copy of the hepatitis C treatments consultation for your reference.
We are seeking feedback on these proposals by 25 May 2016. Final decisions will be made by the PHARMAC Board in time for implementation from as early as 1 July 2016.
Please feel free to contact me should you have any questions.
So it looks like there will be a range of options for GT1's, but still no even mention of daclatisvir or anything as useful for GT3's. Kiwis could make submissions
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716